Last reviewed: June 19, 2026

Last updated: June 19, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

The first dose of semaglutide typically begins at 0.25 mg, a low starting point designed to minimize gastrointestinal side effects while your body adapts to the medication. However, how your body responds to this initial dose depends partly on genetic factors that determine your peptide sensitivity and appetite regulation pathways. PlexusDx uses precision genetic testing to predict your response pattern before treatment starts, allowing your care team to anticipate your dosing trajectory and potential side effects.

Understanding Your Starting Dose and Titration Timeline

The standard semaglutide protocol begins with a 0.25 mg injection once weekly for four weeks. This cautious approach allows your body to adjust to the medication's effects on appetite signaling and blood sugar regulation. Most patients then progress to 0.5 mg weekly for another four weeks before advancing further, though individual timelines vary based on tolerance and weight loss response.

Your dose may need to increase over time as your body adapts, but at PlexusDx, your monthly price stays flat regardless of dose level. This pricing structure removes the financial barrier to finding your optimal therapeutic dose, whether that ends up being 0.5 mg, 1 mg, 1.7 mg, or 2 mg weekly. The goal is reaching the dose that produces meaningful weight loss and manageable side effects for your specific metabolism.

Titration speed matters because jumping doses too quickly can trigger nausea, vomiting, or constipation that leads patients to stop treatment. Slower progression allows your gastrointestinal system and hunger hormones to recalibrate gradually. Your PlexusDx care team monitors your response weekly and adjusts your titration plan based on both your reported symptoms and your weight loss trajectory.

How Genetic Variants Predict Your Medication Response

Your genes control how your body produces and responds to GLP-1 receptors, the cellular locks that semaglutide opens to reduce hunger. PlexusDx Precision Peptide Genetic Test analyzes four critical variants—GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313—that directly influence your appetite regulation system. These genetic markers help predict whether you'll experience rapid weight loss, modest weight loss, side effect sensitivity, or medication tolerance at standard doses.

Patients carrying certain FTO variants typically show slower initial weight loss in the first month, not because the medication is failing, but because their genetic background affects how efficiently they mobilize stored fat. Conversely, GLP1R variants can indicate higher medication sensitivity, meaning lower doses may produce significant appetite suppression and weight loss. Understanding these patterns before your first injection helps PlexusDx set realistic expectations and design a dosing strategy aligned with your genetic profile rather than generic protocols.

The Precision Peptide Genetic Test maps 14 distinct metabolic pathways and 150+ genetic insights, giving your care team a biological blueprint of your weight loss potential. This $99 add-on test, taken after your first month on treatment, reveals whether your genetics favor oral or injection formulations, predict your side effect profile, and identify the dose range most likely to deliver results for your unique peptide pathway.

First-Month Side Effects and How to Manage Them

Nausea ranks as the most common first-month side effect, typically appearing within hours of your injection and subsiding within 24 to 48 hours as your dose is low. Eating smaller, protein-rich meals and avoiding high-fat foods can significantly reduce nausea intensity. Some patients find that taking their injection on a Friday evening allows weekend rest before returning to normal eating patterns on Monday.

Constipation develops in approximately 20% of patients during the first month because GLP-1 slows gastric emptying and intestinal movement. Increasing water intake to at least 80 ounces daily, adding soluble fiber from sources like oats or psyllium, and gentle movement like walking all support bowel regularity. If constipation persists beyond two weeks despite these measures, your PlexusDx provider may recommend a stool softener or mild laxative.

Vomiting is uncommon at the 0.25 mg starting dose but signals that your current dose is too high for your tolerance threshold. Staying at 0.25 mg for an additional two to four weeks before titrating up gives your body more adjustment time. Genetic variants in your appetite regulation pathways can predispose you to nausea sensitivity, which the Precision Peptide test identifies before dosing begins.

Building Your Personalized Treatment Plan Beyond the First Dose

Your weight loss journey extends far beyond that first 0.25 mg injection—it unfolds across months of gradual dose increases, lifestyle adjustments, and response monitoring. PlexusDx structures personalized plans around your genetic insights, past dieting history, current weight, target weight, and underlying metabolic conditions like prediabetes or sleep apnea. This comprehensive approach ensures your treatment addresses root causes of weight gain, not just appetite suppression.

Oral semaglutide and tirzepatide represent alternative pathways for patients who prefer daily tablets over weekly injections, though they typically require higher starting doses due to lower bioavailability. Compounded versions from licensed 503A pharmacies offer identical active ingredients as brand-name medications at a fraction of the cost, with no insurance requirements and HSA/FSA eligibility. PlexusDx serves all 50 states and adjusts your medication type and formulation based on your genetic profile and personal preference.

Your first month establishes baseline data—starting weight, hunger scores, energy levels, and side effect patterns—that PlexusDx uses to forecast your long-term response. If your genetic test suggests you may benefit from a dual-peptide approach, your care team can transition you to GLP-Squared (semaglutide plus tirzepatide combined), which targets multiple appetite pathways simultaneously. Regular follow-ups every two to four weeks ensure your dose optimization stays aligned with your weight loss curve and quality of life.

How Your Genetics Influence GLP-1 Response

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Precision Peptide Genetic Test starts at $99 add-on. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

What should I expect during the first week after my first semaglutide dose?

During your first week, mild nausea may appear within hours of your injection and typically fade within 24 to 48 hours as your dose settles. Most patients notice reduced hunger by day three or four, with cravings shifting significantly by the end of week one. Eating slowly, choosing protein-rich foods, and staying hydrated support your body's adaptation during this initial phase.

How much weight will I lose in the first month of treatment?

First-month weight loss averages 2 to 4 pounds, though genetic factors significantly influence individual results. Patients with certain FTO variants may lose weight more gradually in month one but accelerate in months two through four, while others see rapid early losses. PlexusDx Precision Peptide Genetic Test predicts your specific weight loss trajectory based on your genetic profile, helping set realistic monthly expectations aligned with your biology.

Does PlexusDx charge more if my dose increases beyond the starting level?

No. PlexusDx pricing remains flat whether you stay at 0.25 mg or advance to 2 mg weekly—your dose may go up, but your price won't. Compounded semaglutide injections start at $149 per month across all dose levels, removing financial barriers to finding your optimal therapeutic dose without monthly surprise bills.

Is it safe to stay on a low dose like 0.25 mg if I'm experiencing side effects?

Yes, staying at 0.25 mg for six to eight weeks is safe and often necessary for patients with genetic predispositions to medication sensitivity. Extended time at lower doses allows your gastrointestinal system to fully adjust while still producing meaningful appetite reduction and weight loss. Your PlexusDx provider monitors your response and advances only when both tolerability and weight loss are adequate.

How does the Precision Peptide Genetic Test change my first-dose strategy?

The Precision Peptide Genetic Test, taken after your first month, reveals whether your genetics favor rapid dose escalation or slower titration, and whether injection or oral formulations suit your peptide pathways better. If testing shows you carry variants linked to high medication sensitivity, your care team may slow future dose increases to minimize side effects. For patients with variants supporting faster advancement, your team can confidently escalate doses weekly rather than every four weeks, accelerating your results.

Related Reading

Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.

Real prescribers. Published prices. No surprises.

Licensed providers in all 50 states. Online intake. No insurance, no membership required.

Start My Intake →

~60 seconds · $0 charged until your provider approves